ARK Investment Management - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$231,659,000
-5.1%
9,713,160
-18.1%
0.43%
-11.1%
Q1 2021$244,114,000
-27.5%
11,855,947
-13.7%
0.48%
-45.9%
Q4 2020$336,661,000
-3.3%
13,741,254
+11.8%
0.90%
-56.6%
Q3 2020$348,016,000
+485.9%
12,293,033
-1.5%
2.06%
+223.0%
Q2 2020$59,400,000
+92.4%
12,478,934
+44.3%
0.64%
-16.9%
Q1 2020$30,871,000
+23.0%
8,647,311
+18.9%
0.77%
+21.5%
Q4 2019$25,095,000
-11.5%
7,273,840
+2.8%
0.63%
+2.3%
Q3 2019$28,371,000
+25.2%
7,074,965
+0.5%
0.62%
+8.4%
Q2 2019$22,665,000
-37.6%
7,038,885
+33.1%
0.57%
-45.0%
Q1 2019$36,327,000
+95.1%
5,287,713
+28.4%
1.04%
+37.3%
Q4 2018$18,620,000
-39.3%
4,119,479
+1.9%
0.76%
-18.4%
Q3 2018$30,669,000
+9.2%
4,040,735
+23.7%
0.93%
-9.9%
Q2 2018$28,091,000
+59.0%
3,266,428
+35.7%
1.03%
+17.3%
Q1 2018$17,665,000
+7.2%
2,406,723
+48.1%
0.88%
-33.2%
Q4 2017$16,483,000
+90.6%
1,625,501
+112.4%
1.31%
-22.0%
Q2 2017$8,647,000
+21.8%
765,191
+21.5%
1.68%
-17.7%
Q1 2017$7,099,000
+45.7%
629,915
+28.0%
2.05%
+15.5%
Q4 2016$4,871,000492,0641.77%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$129,455,4524.13%
Eversept Partners, LP 2,200,999$12,325,5941.08%
Kynam Capital Management, LP 776,662$4,349,3070.67%
SILVERARC CAPITAL MANAGEMENT, LLC 374,422$2,096,7630.60%
Lion Point Capital, LP 596,803$3,109,0000.44%
Knott David M Jr 200,100$1,1210.42%
FEDERATED HERMES, INC. 18,085,938$101,281,2530.28%
Atom Investors LP 95,520$534,9120.27%
BOULDER HILL CAPITAL MANAGEMENT LP 20,200$113,1200.09%
HARBOURVEST PARTNERS LLC 49,363$276,4330.09%
View complete list of SERES THERAPEUTICS INC shareholders